Dr. Reddy's Laboratories Ltd. closed 7.57% short of its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Stay informed with the Dr Reddys Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Dr. Reddy's Laboratories Ltd. closed 7.13% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Reddy’s Laboratories Ltd has broken out of a volatility contraction base (VCB) pattern that developed over the past 7–8 ...

Dr. Reddy's faces revenue slowdown post gRevlimid boost, but new investments and partnerships offer long-term growth ...

Boosts Total Shareholding to 8.216% Jun 05 2025 10:40 AM Dr Reddys Laboratories Shares Rise in Today's Trading Session Jun 04 2025 11:17 AM ...

With the current price at Rs 1,358.50, Dr Reddys Laboratories is experiencing notable trading activity and remains an ...

Alvotech and Dr Reddy's entered into a collaboration and license agreement to co-develop, manufacture and commercialize a ...

Dr. Reddy's Laboratories, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1349.9. The stock has experienced fluctuations today ...

Dr Reddy's shares soar 3.54% after Alvotech partnership for Keytruda biosimilar, enhancing global reach in cancer ...

Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...